UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND INHIBITOR AS PROGNOSTIC MARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND LYMPH NODE METASTASES

被引：0
|
作者：
Lumachi, F. [1 ]
Marino, F. [2 ]
Santeufemia, D. A. [3 ]
Chiara, G. B. [3 ]
Basso, S. M. [3 ]
机构：
[1] Univ Padua, Sch Med, Dept Surg & Gastroenterol Sci, Padua, Italy
[2] Univ Padua, Dept Pathol, Sch Med, I-35100 Padua, Italy
[3] S Maria Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in small cell carcinoma of the lung and non-small cell carcinoma of the lung
    Wajima, T
    VonHoff, DD
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2264 - P2264
  • [2] The urokinase-type plasminogen activator system in resected non-small-cell lung cancer
    Salden, M
    Splinter, TAW
    Peters, HA
    Look, MP
    Timmermans, M
    van Meerbeeck, JPAM
    Foekens, JA
    ANNALS OF ONCOLOGY, 2000, 11 (03) : 327 - 332
  • [3] Presence of urokinase plasminogen activator, its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer
    Pappot, H
    Pfeiffer, P
    GrondahlHansen, J
    Skov, BG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (01) : 177 - 182
  • [4] Urokinase-type Plasminogen Activator and Plasminogen-activator-inhibitor Type 1 Predict Metastases in Good Prognosis Breast Cancer Patients
    de Cremoux, Patricia
    Grandin, Laure
    Dieras, Veronique
    Savignoni, Alexia
    Degeorges, Armelle
    Salmon, Remy
    Bollet, Marc A.
    Reyal, Fabien
    Sigal-Zafrani, Brigitte
    Vincent-Salomon, Anne
    Sastre-Garau, Xavier
    Magdelenat, Henri
    Mignot, Laurent
    Fourquet, Alain
    ANTICANCER RESEARCH, 2009, 29 (05) : 1475 - 1482
  • [5] Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer
    Knoop, A
    Andreasen, PA
    Andersen, JA
    Hansen, S
    Lænkholm, AV
    Simonsen, ACW
    Andersen, J
    Overgaard, J
    Rose, C
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 932 - 940
  • [6] Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer
    A Knoop
    PA Andreasen
    JA Andersen
    S Hansen
    A-V Lænkholm
    ACW Simonsen
    J Andersen
    J Overgaard
    C Rose
    British Journal of Cancer, 1998, 77 : 932 - 940
  • [7] Urokinase-type plasminogen activator and plasminogen activator-inhibitor-1 related signalling pathways differ between primary breast cancers and lymph node metastases
    Malinowsky, K.
    Wolff, C.
    Berg, D.
    Schuster, T.
    Walch, A.
    Bronger, H.
    Mannsberger, H.
    Schmidt, C.
    Korf, U.
    Hoefler, H.
    Becker, K. -F.
    VIRCHOWS ARCHIV, 2011, 459 : S5 - S6
  • [8] Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry
    Pappot, H
    Skov, BG
    Pyke, C
    GrondahlHansen, J
    LUNG CANCER, 1997, 17 (2-3) : 197 - 209
  • [9] Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer
    Hasui, Y
    Marutsuka, K
    Asada, Y
    Osada, Y
    UROLOGY, 1996, 47 (01) : 34 - 37
  • [10] Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response
    Setiawan, Lyana
    Setiabudy, Rahajuningsih
    Kresno, Siti Boedina
    Sutandyo, Noorwati
    Syahruddin, Elisna
    Jovianti, Frederica
    Nadliroh, Siti
    Mubarika, Sofia
    Setiabudy, Rianto
    Siregar, Nurjati C.
    CANCER BIOMARKERS, 2024, 39 (02) : 137 - 153
12345